Xi, Zhouhuan
Vats, Abhishek http://orcid.org/0000-0002-4797-2136
Sahel, José-Alain http://orcid.org/0000-0002-4831-1153
Chen, Yuanyuan
Byrne, Leah C. http://orcid.org/0000-0002-3229-4993
Funding for this research was provided by:
China Scholarship Council
Third Xiangya Hospital Xiangya School of Medicine
U.S. Department of Health & Human Services | NIH | National Eye Institute (R01EY030991, R01EY030991)
U.S. Department of Health & Human Services | National Institutes of Health (UG3MH120094, P30 EY08098)
Research to Prevent Blindness (Career Development Award)
Foundation Fighting Blindness (Individual Investigator Award)
U.S. Department of Health & Human Services | National Institutes of Health
Eye and Ear Foundation of Pittsburgh
U.S. Department of Health & Human Services | NIH | National Eye Institute
Article History
Received: 5 March 2022
Accepted: 29 November 2022
First Online: 13 December 2022
Competing interests
: J.A.S. is a co-founder of Avista Therapeutics and Vegavect. L.C.B. is an inventor on patent applications on AAV capsid variants and a co-founder of Avista Therapeutics and Vegavect. The remaining authors declare no competing interests.